MCL1, a highly regulated member of the BCL2 family, is frequently found to be amplified or overexpressed in hematologic cancers
Optimized PK Profile
Potential for maximal target engagement and improved cardiac safety
About
A seasoned team experienced in developing cancer medicines to create a fully integrated oncology company.